GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Olink Holding AB (NAS:OLK) » Definitions » Net Current Asset Value

Olink Holding AB (Olink Holding AB) Net Current Asset Value : $1.32 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Olink Holding AB Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Olink Holding AB's net current asset value per share for the quarter that ended in Dec. 2023 was $1.32.

The historical rank and industry rank for Olink Holding AB's Net Current Asset Value or its related term are showing as below:

OLK' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 15.83   Med: 19.05   Max: 25.9
Current: 17.69

During the past 5 years, the highest Price-to-Net-Current-Asset-Value Ratio of Olink Holding AB was 25.90. The lowest was 15.83. And the median was 19.05.

OLK's Price-to-Net-Current-Asset-Value is ranked worse than
87.69% of 130 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.295 vs OLK: 17.69

Olink Holding AB Net Current Asset Value Historical Data

The historical data trend for Olink Holding AB's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olink Holding AB Net Current Asset Value Chart

Olink Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
-0.87 -0.55 1.15 0.98 1.32

Olink Holding AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.60 1.48 1.32 1.32

Competitive Comparison of Olink Holding AB's Net Current Asset Value

For the Diagnostics & Research subindustry, Olink Holding AB's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olink Holding AB's Price-to-Net-Current-Asset-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Olink Holding AB's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Olink Holding AB's Price-to-Net-Current-Asset-Value falls into.



Olink Holding AB Net Current Asset Value Calculation

Olink Holding AB's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(263.466-99.554-0-0)/124.343
=1.32

Olink Holding AB's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(263.466-99.554-0-0)/124.343
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olink Holding AB  (NAS:OLK) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Olink Holding AB Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Olink Holding AB's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Olink Holding AB (Olink Holding AB) Business Description

Traded in Other Exchanges
Address
Uppsala Science Park, Uppsala, SWE, SE-75183
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the Americas, China, EMEA (Excluding Sweden) Japan, and other regions.